Publications by authors named "Wim Witjes"

Claim this Profile
S
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis.
Ken Herrmann, Jochen Walz, Steven MacLennan, Alberto Briganti, Philip Cornford, Wim Witjes

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early complications after penile prosthesis surgery: findings from the PHOENIX multicenter registry.
Koenraad Van Renterghem, Helene De Bruyn, Alvaro Yebes, Ross Calopedos, Federico Deho, Wim Witjes

Int J Impot Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer-related Events in Patients with Synchronous Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate; Data from the HORRAD Trial.
Liselotte M S Boevé, Maarten C C M Hulshof, Paul C M S Verhagen, Jos W R Twisk, Wim P J Witjes

Eur Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SATURN: A Multinational, Multicentre, Prospective Surgical Registry for Male Urinary Incontinence Surgery Across Europe with Planned 10-year Follow-up.
Nikesh Thiruchelvam, John Heesakkers, Rizwan Hamid, Frank Martens, Frank Van der Aa, Wim Witjes

Eur Urol Focus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results at 1 Year from SATURN, A European, Prospective, Multicenter Registry for Male Stress Urinary Incontinence Surgery.
John Heesakkers, Frank Martens, Nikesh Thiruchelvam, Wim Witjes, Christien Caris

Eur Urol Focus· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SATURN: A European, Prospective, Multicentre Registry for Male Stress Urinary Incontinence Surgery.
Frank Martens, John Heesakkers, Frank Van der Aa, Nikesh Thiruchelvam, Wim Witjes

Eur Urol Open Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial.
Christine G J I van Straten, Christien Caris, Marc-Oliver Grimm, Marc Colombel, Tim Muilwijk, Wim P J Witjes

Eur Urol Open Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries.
Lydia E Makaroff, Alex Filicevas, Shannon Boldon, Patrick Hensley, Peter C Black, Wim P J Witjes

Eur Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [Lu]Lu-PSMA Radioligand Therapy.
Stefano Fanti, Alberto Briganti, Louise Emmett, Karim Fizazi, Silke Gillessen, Wim Witjes

Eur Urol Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([Lu]Lu-PSMA).
Stefano Fanti, Jolanta Kunikowska, Jochen Walz, Wim Witjes, Anders Bjartell

Eur J Nucl Med Mol Imaging· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European Registry Evaluating Symptomatic Effectiveness of Pharmacologically Treated Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Enlargement: Lessons Learned.
Andrea Tubaro, Mark Speakman, Alexandre de la Taille, Louis Martínez-Piñeiro, Richard Berges, Wim Witjes

J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11.
Mariana Reza, Manfred Wirth, Teuvo Tammela, Virgilio Cicalese, Francisco Gomez Veiga, Wim Witjes

Eur Urol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial.
Liselotte Boevé, Maarten C C M Hulshof, Paul C M S Verhagen, Jos W R Twisk, Wim P J Witjes

Eur Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment: Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry.
Sachin Malde, Anup Patel, Luis Martínez-Piñeiro, Alexandre de la Taille, Anders Bjartell, Wim Witjes

Eur Urol Focus· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS".
Marc-Oliver Grimm, Antoine G van der Heijden, Marc Colombel, Tim Muilwijk, Luis Martínez-Piñeiro, Wim P J Witjes

Eur Urol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Emre Karabay and İlker Tınay's Letter to the Editor re: Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS". Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066.
Marc-Oliver Grimm, Christien Caris, Wim P J Witjes,

Eur Urol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.
Peter F A Mulders, Luis Martínez-Piñeiro, Axel Heidenreich, Marko Babjuk, Marc Colombel, J Alfred Witjes, Wim P J Witjes

Eur Urol Focus· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.
Liselotte M S Boevé, Maarten C C M Hulshof, André N Vis, Aeilko H Zwinderman, Jos W R Twisk, Wim P J Witjes

Eur Urol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.
Ashish M Kamat, Roger Li, Michael A O'Donnell, Peter C Black, Morgan Roupret, Wim P Witjes, J Alfred Witjes

Eur Urol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
Daniel Schneider, Giampaolo Bianchini, Denis Horgan, Stefan Michiels, Wim Witjes

Public Health Genomics· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: DNA-repair Defects and Olaparib in Metastatic Prostate Cancer.
Wim P J Witjes

Eur Urol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis.
Siebren Dijkstra, Wim P J Witjes, Erik P M Roos, Peter L M Vijverberg, Arno D H Geboers

Springerplus· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation.
Rianne J M Lammers, Jan C M Hendriks, O Rodriguez Faba Rodriguez Faba, Wim P J Witjes, Joan Palou, J Alfred Witjes

World J Urol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS).
Manfred Wirth, Teuvo Tammela, Virgilio Cicalese, Francisco Gomez Veiga, Karl Delaere, Wim Witjes

Eur Urol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply from authors re: Bertrand Tombal. Zometa European Study (ZEUS): another failed crusade for the holy grail of prostate cancer bone metastases prevention? Eur Urol 2015;67:492-4: ZEUS: the quest for the holy grail of prostate cancer bone metastases prevention continues.
Wim P J Witjes, Anup Patel, Manfred Wirth

Eur Urol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis